Jeroen Meulemans1,2, Pierre Delaere1, Vincent Vander Poorten1,2. 1. Department of Otorhinolaryngology-Head and Neck Surgery, University Hospital Leuven. 2. Department of Oncology, Section Head and Neck Oncology, KU Leuven, Leuven, Belgium.
Abstract
PURPOSE OF REVIEW: To identify and review the recent literature on clinical applications, outcome, and new developments in photodynamic therapy (PDT) for the treatment of head and neck cancer. RECENT FINDINGS: Although PDT and surgery have a similar local control and recurrence rate, the gold standard of treatment for early-stage oral cavity cancer remains local surgery with, on indication, concurrent treatment of the neck. PDT proves its value in treatment of patients with field cancerization and patients with superficial recurrence after previous surgery and/or radiation, in whom surgical salvage would entail important morbidity. PDT is also promising as an adjuvant treatment after surgery in the presence of macroscopic or microscopic involved margins, in patients where reresection or reirradiation would imply an unacceptable risk. Recent progress in the field of PDT focuses on development and clinical application of new photosensitizing agents, photochemical internalization, and photoimmunotherapy. SUMMARY: The value of PDT in specific well-selected head and neck cancer clinical scenarios is well established. The basic research field is rapidly evolving and experimental findings are promising, maybe eventually leading to optimized results, less side-effects, and more indications.
PURPOSE OF REVIEW: To identify and review the recent literature on clinical applications, outcome, and new developments in photodynamic therapy (PDT) for the treatment of head and neck cancer. RECENT FINDINGS: Although PDT and surgery have a similar local control and recurrence rate, the gold standard of treatment for early-stage oral cavity cancer remains local surgery with, on indication, concurrent treatment of the neck. PDT proves its value in treatment of patients with field cancerization and patients with superficial recurrence after previous surgery and/or radiation, in whom surgical salvage would entail important morbidity. PDT is also promising as an adjuvant treatment after surgery in the presence of macroscopic or microscopic involved margins, in patients where reresection or reirradiation would imply an unacceptable risk. Recent progress in the field of PDT focuses on development and clinical application of new photosensitizing agents, photochemical internalization, and photoimmunotherapy. SUMMARY: The value of PDT in specific well-selected head and neck cancer clinical scenarios is well established. The basic research field is rapidly evolving and experimental findings are promising, maybe eventually leading to optimized results, less side-effects, and more indications.
Authors: Shahid Ali Siddiqui; Shaista Siddiqui; M A Bilal Hussain; Shakir Khan; Hui Liu; Kafil Akhtar; Syed Abrar Hasan; Ibne Ahmed; Srivalleesha Mallidi; Amjad P Khan; Filip Cuckov; Colin Hopper; Stephen Bown; Jonathan P Celli; Tayyaba Hasan Journal: Photodiagnosis Photodyn Ther Date: 2022-03-31 Impact factor: 3.577
Authors: Yanna Liu; Marcel H A M Fens; Bo Lou; Nicky C H van Kronenburg; Roel F M Maas-Bakker; Robbert J Kok; Sabrina Oliveira; Wim E Hennink; Cornelus F van Nostrum Journal: Pharmaceutics Date: 2020-04-09 Impact factor: 6.321
Authors: Yanna Liu; Luca Scrivano; Julia Denise Peterson; Marcel H A M Fens; Irati Beltrán Hernández; Bárbara Mesquita; Javier Sastre Toraño; Wim E Hennink; Cornelus F van Nostrum; Sabrina Oliveira Journal: Mol Pharm Date: 2020-03-13 Impact factor: 4.939